USE OF CANAKINUMAB

Use of an IL-1β inhibitor such as canakinumab for the treatment and/or prevention of osteoarthritis and complications related thereto.

Saved in:
Bibliographic Details
Main Authors SCHIEKER, Mattias, MINDEHOLM, Linda, PRAESTGAARD, Jens
Format Patent
LanguageEnglish
Published 02.12.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Use of an IL-1β inhibitor such as canakinumab for the treatment and/or prevention of osteoarthritis and complications related thereto.
Bibliography:Application Number: US201817053602